GB Patent

GB9609932D0 — Use of IL-12 and IFN alpha for the treatment of infectious diseases

Assigned to F Hoffmann La Roche AG · Expires 1996-07-17 · 30y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: GB9609932D0
Jurisdiction: GB
Classification: —
Expires: 1996-07-17
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.